𝔖 Bobbio Scriptorium
✦   LIBER   ✦

PCN29 THE COST SAVINGS ASSOCIATED WITH BEVACIZUMAB PLUS CISPLATIN AND GEMCITABINE (BEVACIZUMAB-BASED THERAPY) TREATMENT COMPARED WITH CETUXIMAB PLUS VINORELBINE AND CISPLATIN (CETUXIMAB-BASED THERAPY) IN PATIENTS WITH ADVANCED OR RECURRENT NON-SMALL CELL CANCER (NSCLC) ACROSS FOUR EUROPEAN COUNTRIES

✍ Scribed by M Nuijten; C Chouaid; A Vergnenegre


Book ID
118610864
Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
88 KB
Volume
12
Category
Article
ISSN
1098-3015

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


PCN14 AN INDIRECT COMPARISON OF THE EFFI